Literature DB >> 29601852

Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and their association with type 2 diabetes and impaired renal function.

Eliecer Coto1, Carmen Díaz-Corte2, Salvador Tranche3, Juan Gómez4, Belén Alonso4, Sara Iglesias4, Julián R Reguero5, Carlos López-Larrea6, Pablo Coto-Segura7.   

Abstract

The NF-kappaB pathway might play a role in the pathogenesis of renal disease and type 2 diabetes (T2DM). Our aim was to determine whether common polymorphisms in NF-kappaB genes were associated with impaired renal function and T2DM in a cohort of healthy elderly individuals. We studied 487 individuals, all Caucasian and aged 65-85 years. A total of 104 (21%) had impaired renal function (estimated glomerular filtration rate, eGFR < 60) and 146 (30%) were classified as diabetics. The genotypes of 4 common variants were determined through PCR-RFLP or fluorescent capillary electrophoresis. The NFKB1 variants were significantly associated with T2DM: rs7667496 p = 0.01, OR = 1.68; and rs28362491 p = 0.02, OR = 1.67. They remained significantly associated in a multiple logistic regression with age, gender, hypertension, body mass index, and cholesterol. There was a trend toward the association of these variants with eGFR < 60. The two NFKB1 variants were in linkage disequilibrium (D' = -0.86), and homozygous for the two non-risk alleles (rs7667496 CC + rs28362491 II), were significantly more common in the non-diabetics (p = 0.02). In our cohort the NFKB1 variation was an independent risk factor for developing T2DM. Additional studies to confirm this association are of special interest, as well as studies to give a functional explanation to the genetic association.
Copyright © 2018 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genetic association; Impaired renal function; NF-KB pathway; Type 2 diabetes

Mesh:

Substances:

Year:  2018        PMID: 29601852     DOI: 10.1016/j.humimm.2018.03.008

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  8 in total

Review 1.  Probiotic mediated NF-κB regulation for prospective management of type 2 diabetes.

Authors:  Rabia Bhardwaj; Brij Pal Singh; Nitika Sandhu; Niharika Singh; Ravinder Kaur; Namita Rokana; Kumar Siddharth Singh; Vishu Chaudhary; Harsh Panwar
Journal:  Mol Biol Rep       Date:  2020-01-09       Impact factor: 2.316

2.  Sacubitril/valsartan treatment has differential effects in modulating diabetic kidney disease in db/db mice and KKAy mice compared with valsartan treatment.

Authors:  Komuraiah Myakala; Bryce A Jones; Xiaoxin X Wang; Moshe Levi
Journal:  Am J Physiol Renal Physiol       Date:  2021-04-19

3.  Comparison of efficacy of SHENQI compound and rosiglitazone in the treatment of diabetic vasculopathy analyzing multi-factor mediated disease-causing modules.

Authors:  Hong Gao; Yuhong Duan; Xiaoxu Fu; Hongyan Xie; Ya Liu; Haipo Yuan; Mingyang Zhou; Chunguang Xie
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

4.  Gene Variant in the NF-κB Pathway Inhibitor NFKBIA Distinguishes Patients with Psoriatic Arthritis within the Spectrum of Psoriatic Disease.

Authors:  Pablo Coto-Segura; Eliecer Coto; Leire González-Lara; Belén Alonso; Juan Gómez; Elías Cuesta-Llavona; Rubén Queiro
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411

Review 5.  Genetic Variants of the NF-κB Pathway: Unraveling the Genetic Architecture of Psoriatic Disease.

Authors:  Rubén Queiro; Pablo Coto; Leire González-Lara; Eliecer Coto
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

6.  Network pharmacology study of Yishen capsules in the treatment of diabetic nephropathy.

Authors:  Jingai Fang; Chendan Wang; Jie Zheng; Yuxiang Liu
Journal:  PLoS One       Date:  2022-09-12       Impact factor: 3.752

7.  Polydatin and polydatin-loaded chitosan nanoparticles attenuate diabetic cardiomyopathy in rats.

Authors:  Fatma Mostafa; Adel Abdel-Moneim; Manal Abdul-Hamid; Sanaa R Galaly; Hanaa M Mohamed
Journal:  J Mol Histol       Date:  2021-01-03       Impact factor: 2.611

8.  MiR-144-induced KLF2 inhibition and NF-kappaB/CXCR1 activation promote neutrophil extracellular trap-induced transfusion-related acute lung injury.

Authors:  Aiping Le; Yize Wu; Wei Liu; Chenggao Wu; Piaoping Hu; Juan Zou; Linju Kuang
Journal:  J Cell Mol Med       Date:  2021-06-13       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.